AAPL305.84-3.07 (-0.99%) ▼|ABBV245.39-5.55 (-2.21%) ▼|ABT106.58+0.88 (+0.83%) ▲|ACN166.74+0.82 (+0.49%) ▲|ADBE254.62+4.21 (+1.68%) ▲|AMAT512.81+5.14 (+1.01%) ▲|AMD478.61+2.46 (+0.52%) ▲|AMGN382.72-2.44 (-0.63%) ▼|AMT173.79+0.43 (+0.25%) ▲|AMZN285.66+14.08 (+5.18%) ▲|AVGO382.39-6.89 (-1.77%) ▼|AXP343.58+7.33 (+2.18%) ▲|BA227.74+11.60 (+5.37%) ▲|BAC62.26+0.31 (+0.49%) ▲|BKNG191.70-1.20 (-0.62%) ▼|BLK1,117.69+27.30 (+2.50%) ▲|BMY64.70-0.62 (-0.94%) ▼|BNY155.70-0.63 (-0.40%) ▼|BRK-B514.74+3.20 (+0.63%) ▲|C132.30+0.52 (+0.39%) ▲|CAT826.82+12.01 (+1.47%) ▲|CL92.07+0.77 (+0.84%) ▲|CMCSA24.66+0.70 (+2.92%) ▲|COF216.54+7.53 (+3.60%) ▲|COP118.59-1.90 (-1.57%) ▼|COST951.41-0.48 (-0.05%) ▼|CRM188.30+4.28 (+2.33%) ▲|CSCO115.55-0.44 (-0.38%) ▼|CVS105.19+0.76 (+0.73%) ▲|CVX194.36-2.47 (-1.25%) ▼|DE614.57+21.90 (+3.70%) ▲|DHR196.38+1.40 (+0.72%) ▲|DIS98.03+1.84 (+1.91%) ▲|DUK125.26-0.18 (-0.14%) ▼|EMR152.21+2.39 (+1.60%) ▲|FDX308.24+0.84 (+0.27%) ▲|GD383.62+0.20 (+0.05%) ▲|GE366.77+6.70 (+1.86%) ▲|GEV991.56+1.27 (+0.13%) ▲|GILD129.48-0.73 (-0.56%) ▼|GM88.55-0.31 (-0.35%) ▼|GOOG367.11+10.46 (+2.93%) ▲|GOOGL367.39+11.26 (+3.16%) ▲|GS1,018.16-0.22 (-0.02%) ▼|HD336.34+4.38 (+1.32%) ▲|HON248.33+5.28 (+2.17%) ▲|IBM225.61+1.96 (+0.87%) ▲|INTC89.76-0.44 (-0.49%) ▼|INTU319.66+3.59 (+1.14%) ▲|ISRG370.94+17.61 (+4.98%) ▲|JNJ252.61-3.74 (-1.46%) ▼|JPM354.44+2.65 (+0.75%) ▲|KO86.99-0.60 (-0.69%) ▼|LIN481.97+3.59 (+0.75%) ▲|LLY1,125.94-22.90 (-1.99%) ▼|LMT587.41+4.67 (+0.80%) ▲|LOW209.30+1.49 (+0.72%) ▲|LRCX290.94-2.08 (-0.71%) ▼|MA574.34+1.24 (+0.22%) ▲|MCD271.66+1.02 (+0.38%) ▲|MDLZ62.23-0.08 (-0.13%) ▼|MDT86.15+0.76 (+0.88%) ▲|META584.03+27.32 (+4.91%) ▲|MMM178.69+2.41 (+1.37%) ▲|MO68.15-0.18 (-0.26%) ▼|MRK128.23-1.98 (-1.52%) ▼|MS210.86+0.44 (+0.21%) ▲|MSFT484.58+19.86 (+4.27%) ▲|MU816.31-6.72 (-0.82%) ▼|NEE86.45-0.47 (-0.54%) ▼|NFLX72.37+0.66 (+0.92%) ▲|NKE42.34+0.63 (+1.50%) ▲|NOW115.07+3.84 (+3.45%) ▲|NVDA205.39+4.64 (+2.31%) ▲|ORCL135.67+5.80 (+4.47%) ▲|PEP139.74+0.18 (+0.13%) ▲|PFE24.98-0.03 (-0.12%) ▼|PG145.36+0.87 (+0.60%) ▲|PLTR124.90+1.84 (+1.50%) ▲|PM190.82-0.01 (0.00%) ▼|QCOM147.66+0.05 (+0.03%) ▲|RTX216.50+1.28 (+0.60%) ▲|SBUX104.91-0.34 (-0.32%) ▼|SCHW106.21+0.97 (+0.92%) ▲|SO94.61+0.07 (+0.07%) ▲|SPG229.10-0.28 (-0.12%) ▼|T23.47+0.22 (+0.92%) ▲|TMO579.24+4.94 (+0.86%) ▲|TMUS176.31+3.60 (+2.08%) ▲|TSLA317.57+6.36 (+2.04%) ▲|TXN270.37-5.37 (-1.95%) ▼|UBER71.35+0.99 (+1.41%) ▲|UNH416.19+1.79 (+0.43%) ▲|UNP290.85-1.28 (-0.44%) ▼|UPS106.26+2.04 (+1.96%) ▲|USB63.51+0.50 (+0.79%) ▲|V368.12+1.99 (+0.54%) ▲|VZ47.50+0.69 (+1.46%) ▲|WFC86.76+0.31 (+0.36%) ▲|WMT110.71-0.49 (-0.44%) ▼|XOM154.76-0.68 (-0.44%) ▼|AAPL305.84-3.07 (-0.99%) ▼|ABBV245.39-5.55 (-2.21%) ▼|ABT106.58+0.88 (+0.83%) ▲|ACN166.74+0.82 (+0.49%) ▲|ADBE254.62+4.21 (+1.68%) ▲|AMAT512.81+5.14 (+1.01%) ▲|AMD478.61+2.46 (+0.52%) ▲|AMGN382.72-2.44 (-0.63%) ▼|AMT173.79+0.43 (+0.25%) ▲|AMZN285.66+14.08 (+5.18%) ▲|AVGO382.39-6.89 (-1.77%) ▼|AXP343.58+7.33 (+2.18%) ▲|BA227.74+11.60 (+5.37%) ▲|BAC62.26+0.31 (+0.49%) ▲|BKNG191.70-1.20 (-0.62%) ▼|BLK1,117.69+27.30 (+2.50%) ▲|BMY64.70-0.62 (-0.94%) ▼|BNY155.70-0.63 (-0.40%) ▼|BRK-B514.74+3.20 (+0.63%) ▲|C132.30+0.52 (+0.39%) ▲|CAT826.82+12.01 (+1.47%) ▲|CL92.07+0.77 (+0.84%) ▲|CMCSA24.66+0.70 (+2.92%) ▲|COF216.54+7.53 (+3.60%) ▲|COP118.59-1.90 (-1.57%) ▼|COST951.41-0.48 (-0.05%) ▼|CRM188.30+4.28 (+2.33%) ▲|CSCO115.55-0.44 (-0.38%) ▼|CVS105.19+0.76 (+0.73%) ▲|CVX194.36-2.47 (-1.25%) ▼|DE614.57+21.90 (+3.70%) ▲|DHR196.38+1.40 (+0.72%) ▲|DIS98.03+1.84 (+1.91%) ▲|DUK125.26-0.18 (-0.14%) ▼|EMR152.21+2.39 (+1.60%) ▲|FDX308.24+0.84 (+0.27%) ▲|GD383.62+0.20 (+0.05%) ▲|GE366.77+6.70 (+1.86%) ▲|GEV991.56+1.27 (+0.13%) ▲|GILD129.48-0.73 (-0.56%) ▼|GM88.55-0.31 (-0.35%) ▼|GOOG367.11+10.46 (+2.93%) ▲|GOOGL367.39+11.26 (+3.16%) ▲|GS1,018.16-0.22 (-0.02%) ▼|HD336.34+4.38 (+1.32%) ▲|HON248.33+5.28 (+2.17%) ▲|IBM225.61+1.96 (+0.87%) ▲|INTC89.76-0.44 (-0.49%) ▼|INTU319.66+3.59 (+1.14%) ▲|ISRG370.94+17.61 (+4.98%) ▲|JNJ252.61-3.74 (-1.46%) ▼|JPM354.44+2.65 (+0.75%) ▲|KO86.99-0.60 (-0.69%) ▼|LIN481.97+3.59 (+0.75%) ▲|LLY1,125.94-22.90 (-1.99%) ▼|LMT587.41+4.67 (+0.80%) ▲|LOW209.30+1.49 (+0.72%) ▲|LRCX290.94-2.08 (-0.71%) ▼|MA574.34+1.24 (+0.22%) ▲|MCD271.66+1.02 (+0.38%) ▲|MDLZ62.23-0.08 (-0.13%) ▼|MDT86.15+0.76 (+0.88%) ▲|META584.03+27.32 (+4.91%) ▲|MMM178.69+2.41 (+1.37%) ▲|MO68.15-0.18 (-0.26%) ▼|MRK128.23-1.98 (-1.52%) ▼|MS210.86+0.44 (+0.21%) ▲|MSFT484.58+19.86 (+4.27%) ▲|MU816.31-6.72 (-0.82%) ▼|NEE86.45-0.47 (-0.54%) ▼|NFLX72.37+0.66 (+0.92%) ▲|NKE42.34+0.63 (+1.50%) ▲|NOW115.07+3.84 (+3.45%) ▲|NVDA205.39+4.64 (+2.31%) ▲|ORCL135.67+5.80 (+4.47%) ▲|PEP139.74+0.18 (+0.13%) ▲|PFE24.98-0.03 (-0.12%) ▼|PG145.36+0.87 (+0.60%) ▲|PLTR124.90+1.84 (+1.50%) ▲|PM190.82-0.01 (0.00%) ▼|QCOM147.66+0.05 (+0.03%) ▲|RTX216.50+1.28 (+0.60%) ▲|SBUX104.91-0.34 (-0.32%) ▼|SCHW106.21+0.97 (+0.92%) ▲|SO94.61+0.07 (+0.07%) ▲|SPG229.10-0.28 (-0.12%) ▼|T23.47+0.22 (+0.92%) ▲|TMO579.24+4.94 (+0.86%) ▲|TMUS176.31+3.60 (+2.08%) ▲|TSLA317.57+6.36 (+2.04%) ▲|TXN270.37-5.37 (-1.95%) ▼|UBER71.35+0.99 (+1.41%) ▲|UNH416.19+1.79 (+0.43%) ▲|UNP290.85-1.28 (-0.44%) ▼|UPS106.26+2.04 (+1.96%) ▲|USB63.51+0.50 (+0.79%) ▲|V368.12+1.99 (+0.54%) ▲|VZ47.50+0.69 (+1.46%) ▲|WFC86.76+0.31 (+0.36%) ▲|WMT110.71-0.49 (-0.44%) ▼|XOM154.76-0.68 (-0.44%) ▼|
23.7 C
New York
Monday, August 3, 2026

Tag: FDA TRI

newssourceFORcompanyinformationcontent1releasesmarket

Wave Neuroscience Announces FDA Clearance of MeRT® for PTSD

FIRST-EVER FDA-CLEARED PERSONALIZED CLINICAL TREATMENT SYSTEM FOR POST-TRAUMATIC STRESS DISORDER (PTSD) ESTABLISHES A NEW CATEGORY IN PRECISION MENTAL HEALTHCARENEWPORT BEACH, Calif., June 11, 2026...

Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek®

IRVING, Texas, Aug. 15, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published...

Myra Vision Secures FDA Approval to Initiate US IDE Study in Glaucoma

The ADAPT study will evaluate the safety and effectiveness of the company's Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System CAMPBELL, Calif., Aug. 12, 2025 /PRNewswire/...

Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy

LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United States and Europe,...

Myosin Therapeutics Receives FDA Clearance to Initiate First-in-Human Trial of MT-125 in Glioblastoma

JUPITER, Fla., June 9, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies targeting molecular motors, today announced that the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFDA TRI

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers